Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma (HNSCC)

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma (HNSCC). Study availability and eligibility vary by location and protocol.

31 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma (HNSCC) trial results

Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT04215978

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) San Diego, California, United States
  • UPMC Hillman Cancer Center (Univ Of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Blacktown Cancer And Haematology Centre Blacktown, New South Wales, Australia
View all 30 locations
View Trial Details
Completed

An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

NCT03735628

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Tower Hematology/Oncology Medical Group Beverly Hills, California, United States
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • Rocky Mountain Cancer Centers / Denver, CO Denver, Colorado, United States
  • Gabrail Cancer Center Canton, Ohio, United States
View Trial Details
Completed

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

NCT02764593

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Florida Cancer Center at Orlando Health Orlando, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Louisville Louisville, Kentucky, United States
View Trial Details
Completed

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT02684253

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Active, Not Recruiting

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

NCT05891171

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +64 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Lake City, Florida, United States
  • Research Site Hinsdale, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Medical Oncology Associates of San Diego San Diego, California, United States
View all 87 locations
View Trial Details

Related conditions